Schlaich, M.P., Schmieder, R.E., Bakris, G., Blankestijn, P.J., Bohm, M., Campese, V.M., Francis, D.P., Grassi, G., Hering, D., Katholi, R., Kjeldsen, S., Krum, H., Mahfoud, F., Mancia, G., Messerli, F.H., Narkiewicz, K., Parati, G., Rocha-Singh, K.J., Ruilope, L.M., Rump, L.C., Sica, D.A., Sobotka, P.A., Tsioufis, C., Vonend, O., Weber, M.A., Williams, B., Zeller, T. and Esler, M.D. (2013) International Expert Consensus Statement: Percutaneous Transluminal Renal Denervation for the Treatment of Resistant Hypertension. Journal of the American College of Cardiology, 62, 2031-2045.
http://dx.doi.org/10.1016/j.jacc.2013.08.1616

has been cited by the following article:

• TITLE: Prevalence and Characteristics of Treatment-Resistant Hypertension among Hypertensive Japanese Outpatients

  AUTHORS: Keisuke Okamura, Hidenori Urata

  KEYWORDS: Treatment-Resistant Hypertension, Catheter-Based Renal Sympathetic Denervation, Human

  JOURNAL NAME: International Journal of Clinical Medicine, Vol.6 No.9, September 10, 2015

  ABSTRACT: Aims: To retrospectively investigate the prevalence and characteristics of treatment-resistant hypertension (R-HT) among consecutive hypertensive outpatients, since patients with R-HT are candidates for catheter-based renal sympathetic denervation (RD). Methods: Consecutive hypertensive outpatients (n = 999) were recruited in our hospital. R-HT patients who were candidates for RD had clinic systolic blood pressure > 160 mmHg despite taking three or more antihypertensive drugs including at least one diuretics at higher than standard doses. Results: Our survey indicated that only 26 patients (2.6%) were potential candidates for renal denervation. Candidates for RD showed a significantly higher age (P